Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70

Reuters

06/26

Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70

Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2546221316"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546221316\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546221316?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-26 06:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546221316","market":"fut","top_or_hot":-1,"title":"Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-26 06:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KEQU","symbol_name":"基瓦尼科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDLbVqJxC:1","article_id":"2546221316","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546221316","pubTimestamp":1750890188,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"KEQU":"基瓦尼科技"},"translate_title":"Kewaunee Scientific报告2025财年销售额增长18%；每股净利润跃升至1.70美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KEQU":0.9},"content_text":"Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n    \n\n        Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}